NCT01741519View on ClinicalTrials.gov

Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
DRUG

LDLL600

Comparison of 3 different doses LDLL600 in long-term infusion. 54 PK samples, BP and ECG measurement time points, several local tolerability measurement time points.

DRUG

Brevibloc

Comparison of 3 different doses Esmolol in long-term infusion. 54 PK samples, BP and ECG measurement time points, several local tolerability measurement time points.

Trial Locations (1)

323 00

Cepha s.r.o, Pilsen

Sponsors
All Listed Sponsors
lead

AOP Orphan Pharmaceuticals AG

INDUSTRY

NCT01741519 - Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers | Biotech Hunter | Biotech Hunter